166 related articles for article (PubMed ID: 37639015)
1. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Gkiourtzis N; Michou P; Moutafi M; Glava A; Cheirakis K; Christakopoulos A; Vouksinou E; Fotoulaki M
Eur J Pediatr; 2023 Nov; 182(11):4795-4806. PubMed ID: 37639015
[TBL] [Abstract][Full Text] [Related]
2. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
Hu H; Wang J; Li X; Shen L; Shi D; Meng J
Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
[TBL] [Abstract][Full Text] [Related]
4. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
Front Immunol; 2022; 13():949746. PubMed ID: 36159792
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.
Fatima K; Moeed A; Waqar E; Atif AR; Kamran A; Rizvi H; Suri NF; Haider H; Shuja SH; Khalid M; Minhas AMK
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101816. PubMed ID: 34607067
[TBL] [Abstract][Full Text] [Related]
7. The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials.
Gkiourtzis Ν; Kalopitas G; Vadarlis A; Bakaloudi DR; Dionysopoulos G; Karanika E; Tsekitsidi E; Chourdakis M
J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):e31-e37. PubMed ID: 35758473
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Guo XF; Wang C; Yang T; Li S; Li KL; Li D
Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
[TBL] [Abstract][Full Text] [Related]
10. The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta-analysis of randomized controlled trials.
Haber R; Zarzour F; Ghezzawi M; Saadeh N; Bacha DS; Al Jebbawi L; Chakhtoura M; Mantzoros CS
Diabetes Obes Metab; 2024 May; 26(5):1850-1867. PubMed ID: 38468148
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
Said A; Akhter A
Ann Hepatol; 2017; 16(4):538-547. PubMed ID: 28611274
[TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review.
Nie Q; Li M; Huang C; Yuan Y; Liang Q; Ma X; Qiu T; Li J
J Transl Med; 2024 Mar; 22(1):225. PubMed ID: 38429794
[TBL] [Abstract][Full Text] [Related]
13. Can omega-3 fatty acids be beneficial in pediatric NAFLD? A systematic review and meta-analysis.
Dionysopoulos G; Kalopitas G; Vadarlis A; Bakaloudi DR; Gkiourtzis N; Karanika E; Tsekitsidi E; Chourdakis M
Crit Rev Food Sci Nutr; 2023; 63(27):8545-8553. PubMed ID: 35400251
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
[No Abstract] [Full Text] [Related]
15. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
[TBL] [Abstract][Full Text] [Related]
17. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
18. Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Sun L; Deng C; Gu Y; He Y; Yang L; Shi J
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101876. PubMed ID: 35321843
[TBL] [Abstract][Full Text] [Related]
19. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
Nadeau KJ; Ehlers LB; Zeitler PS; Love-Osborne K
Pediatr Diabetes; 2009 Feb; 10(1):5-13. PubMed ID: 18721166
[TBL] [Abstract][Full Text] [Related]
20. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]